loading

Transcode Therapeutics Inc Aktie (RNAZ) Neueste Nachrichten

pulisher
06:33 AM

Does TransCode Therapeutics Inc. fit your quant trading modelJuly 2025 WrapUp & Accurate Trade Setup Notifications - newser.com

06:33 AM
pulisher
05:44 AM

CK Life Merges Polynoma with TransCode in $125M DealNews and Statistics - IndexBox

05:44 AM
pulisher
05:19 AM

CK Life Sciences sees low geopolitical risks in a US merger - The Standard (HK)

05:19 AM
pulisher
03:59 AM

Multi asset correlation models including TransCode Therapeutics Inc.July 2025 Highlights & Risk Managed Investment Strategies - newser.com

03:59 AM
pulisher
02:53 AM

TransCode Therapeutics (NASDAQ:RNAZ) Earns “Sell (E+)” Rating from Weiss Ratings - Defense World

02:53 AM
pulisher
02:50 AM

Critical Analysis: Century Therapeutics (NASDAQ:IPSC) and TransCode Therapeutics (NASDAQ:RNAZ) - Defense World

02:50 AM
pulisher
02:40 AM

CKLIFE SCIENCES Estimates Completion of TransCode Preferred Stock Conversion in 6 Mths at Earliest - AASTOCKS.com

02:40 AM
pulisher
01:53 AM

How hedge fund analytics apply to TransCode Therapeutics Inc. stockJuly 2025 Decliners & Advanced Technical Signal Analysis - newser.com

01:53 AM
pulisher
Oct 08, 2025

CK Life unit merges with TransCode as Li Ka-shing firm eyes anticancer drugs - South China Morning Post

Oct 08, 2025
pulisher
Oct 08, 2025

TransCode Therapeutics Acquires Polynoma, Secures $25 Million Investment to Advance Oncology Pipeline - citybuzz

Oct 08, 2025
pulisher
Oct 08, 2025

TransCode Therapeutics, Inc. (RNAZ) Stock :Soars as $25M Investment and Polynoma Acquisition Ignite Growth Prospects - parameter.io

Oct 08, 2025
pulisher
Oct 08, 2025

TransCode Therapeutics To Acquire Polynoma; $25M Financing By a Subsidiary Of CK Life Sciences - citybiz

Oct 08, 2025
pulisher
Oct 08, 2025

TransCode Makes Bold Bet On Melanoma Vaccine With Polynoma Buyout - Benzinga

Oct 08, 2025
pulisher
Oct 08, 2025

Transcode announces the acquisition of Polynoma and a $25 mln financing by subsidiary of CK Life Sciences - MarketScreener

Oct 08, 2025
pulisher
Oct 08, 2025

TransCode Therapeutics stock soars after Polynoma acquisition By Investing.com - Investing.com Canada

Oct 08, 2025
pulisher
Oct 08, 2025

TransCode Acquires Polynoma, Secures $25M Strategic Investment | RNAZ Stock News - Stock Titan

Oct 08, 2025
pulisher
Oct 06, 2025

TransCode Therapeutics To Acquire Polynoma, Receive $25M Investment To Advance Key Asset - Stocktwits

Oct 06, 2025
pulisher
Oct 05, 2025

Chart based exit strategy for TransCode Therapeutics Inc.2025 Historical Comparison & Expert Verified Stock Movement Alerts - newser.com

Oct 05, 2025
pulisher
Oct 05, 2025

Strategies to average down on TransCode Therapeutics Inc.2025 Breakouts & Breakdowns & Risk Managed Investment Entry Signals - newser.com

Oct 05, 2025
pulisher
Oct 03, 2025

TransCode Therapeutics Amends Patent License Agreement - TipRanks

Oct 03, 2025
pulisher
Oct 03, 2025

TransCode Therapeutics (NASDAQ:RNAZ) Trading Down 1.5% – What’s Next? - Defense World

Oct 03, 2025
pulisher
Oct 03, 2025

Will TransCode Therapeutics Inc. stock go up soonMarket Activity Report & Growth Oriented Trade Recommendations - newser.com

Oct 03, 2025
pulisher
Sep 30, 2025

Is TransCode Therapeutics Inc. stock bottoming outJuly 2025 Big Picture & Real-Time Volume Analysis Alerts - newser.com

Sep 30, 2025
pulisher
Sep 29, 2025

TransCode Therapeutics Passes Key Proposals at Annual Meeting - MSN

Sep 29, 2025
pulisher
Sep 29, 2025

Developing predictive dashboards with TransCode Therapeutics Inc. dataMarket Sentiment Review & Safe Capital Allocation Plans - newser.com

Sep 29, 2025
pulisher
Sep 28, 2025

TransCode Therapeutics Inc Stock Analysis and ForecastSupport Level Holds & Our Picks = Your Future Gains - earlytimes.in

Sep 28, 2025
pulisher
Sep 27, 2025

What analysts say about TransCode Therapeutics Inc stockShort-Term Trading Alerts & Build a Smarter Portfolio Right Now - earlytimes.in

Sep 27, 2025
pulisher
Sep 26, 2025

A activity2025 Technical Patterns & Real-Time Buy Signal Notifications - newser.com

Sep 26, 2025
pulisher
Sep 22, 2025

What to expect from CPSH in the next 30 daysWatch List & High Accuracy Swing Entry Alerts - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

Is Mineralys Therapeutics Inc. stock poised for growthJuly 2025 Reactions & Free Safe Capital Growth Stock Tips - newser.com

Sep 22, 2025
pulisher
Sep 22, 2025

NGVT stock trend outlook and recovery pathMarket Movement Recap & Safe Entry Momentum Tips - newser.com

Sep 22, 2025
$84.90
price down icon 0.66%
$22.52
price down icon 3.41%
$31.80
price down icon 2.86%
$104.44
price down icon 1.74%
$163.87
price up icon 1.24%
biotechnology ONC
$335.20
price down icon 4.57%
Kapitalisierung:     |  Volumen (24h):